Back to Results
First PageMeta Content
Organofluorides / Biology / Entry inhibitors / Carbamates / Virology / Maraviroc / Antiretroviral drug / CCR5 / Monogram Biosciences / Chemistry / Organic chemistry / HIV/AIDS


U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may
Add to Reading List

Open Document

File Size: 1,01 MB

Share Result on Facebook

City

Burlington / New York City / New Orleans / /

Company

GlaxoSmithKline / Pfizer Inc. / Cargill / Schering-Plough / Monogram Biosciences / /

Country

United States / /

Event

FDA Phase / /

Facility

University College / Medical College of Wisconsin / Columbia University / Tulane University / University Boulevard East Adelphi / Plough Research Institute / University of Utah Medical Center / University of California / Children’s Hospital of Wisconsin / University of Minnesota / Tufts University / Conference Center University of Maryland / The Inn / /

IndustryTerm

virologic response algorithm / care of HIV / travel expenses / HIV treatment / AIDS Care / /

MedicalCondition

HIV / HIV RNA / neuropsychiatric disease / liver disease / Pediatric Infectious Diseases / metabolic diseases / diabetes / concurrent tuberculosis infection / AIDS / MS / disease / cardiovascular disease / HIV disease / /

MedicalTreatment

HAART / antiretroviral treatment / /

OperatingSystem

Microsoft Windows / /

Organization

Columbia University / Division of Antiviral Products / University of Maryland / Antiviral Drugs Advisory Committee / Medical College of Wisconsin / International AIDS Society / University College / office of AIDS Research / University of Utah / California Department of Public Health / University of California / San Francisco / office of Antimicrobial Products / National Institute of Health / International Center for AIDS Care / Tufts University / Tulane University / Schering-Plough Research Institute / REGULAR GOVERNMENT / Congress / U.S. Food and Drug Administration / Advisory Committee Service / Division of Antiviral Drug Products / Children’s Hospital of Wisconsin in Milwaukee / Antiviral Drug Advisory Committee / DEPARTMENT OF HEALTH AND HUMAN SERVICES / Utah Medical Center / University of Minnesota / office of AIDS / /

Person

Doris Strader / Poonam Mishra / Paul T. Tran / Scott Proestel / Susan Ellenburg / D. Michael Marco / D. Victoria A. Cargill / D. Michelle E. Roland / James Goodrich / Marshall Glesby / Mike Westby / Curt Hagedorn / Michael Westby / Enrico P. Veltri / Jim Neaton / Craig W. Hendrix / Debra B. Birnkrant / Jim Goodrich / M.D. Scott Proestel / Dennis O. Dixon / Van Dyke / Michelle Roland / Craig Hendrix / Russell Van Dyke / Debbie Birnkrant / Victoria Cargill / Jeff Murray / Janet Anderson / Howard Mayer / Tracy Swan / John Farley / Peter Havens / Gail Demmler / D. Doris B. Strader / James Neaton / Gladstone / Efficacy Jayvant Heera / Robert M. Grant / Barbara H. McGovern / Alice K. Pau / Michael Marco / /

/

Position

Chief / invited industry representative / clinical neurologist / consumer representative and Co-infection Project Director of Treatment Action Group / Representative / clinical pharmacist / development team leader / professor of medicine / Director of Minority Research and Clinical Studies / Federal Official / biostatistician / Deputy Director / Director / biostatistician / NIAID / Acting Chair / chair / Medical Officer / industry representative / Medical Team Leader / Medical Team Leader / Antiviral Products / Marshall / /

Product

efavirenz / Selzentry / zidovudine / abacavir / lamivudine / CCR5 / /

ProvinceOrState

Minnesota / California / Vermont / Wisconsin / Maryland / /

Technology

virologic response algorithm / genotype / drug development / /

SocialTag